Navigation Links
PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
Date:9/1/2009

BOSTON, Sept. 1 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Robert Baird 2009 Healthcare Conference in New York, NY. James F. Winschel, Jr., Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 10:30 a.m. EDT on Wednesday, September 9, 2009.

A live webcast of this presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at www.PAREXEL.com. A replay of the presentation will be available until November 24, 2009.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 70 locations throughout 52 countries around the world, and has over 9,275 employees. For more information about PAREXEL International visit www.parexel.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

    CONTACT:  Jill Baker, Vice President of Investor Relations
              +1-781-434-4118


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
2. PAREXEL International to Present at the Wachovia Equity Conference
3. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
4. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
5. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
6. PAREXEL Receives BioSingapore Award for Best Performing CRO
7. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
8. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
9. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
10. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
11. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... As Outsourcing of Cell Line Development Services Drives the ... by Expanding their Service Portfolio and Collaborating with Biopharmaceutical ... cell banking market addresses market sizing, emerging trends, and ... in the market. The base year considered is 2015 ... The cell banking market is expected to grow ...
(Date:1/24/2017)... ORANGE COUNTY, Calif. , Jan. 24, 2017 ... respiratory testing solutions, announced today that in ... providing advanced respiratory assessment to the Roche FIREFISH ... muscular atrophy (SMA) develop respiratory insufficiency due to ... alpha motor neurons in the spinal cord. This ...
(Date:1/24/2017)... Reha Technology USA Inc. has ... . The need for Robotic technology in the rehab space ... in the surgical space. Project Walk – Boston ... and adding technology to their continuum of care. They now have ... repetitions which has been shown to improve gait with patients. The ...
(Date:1/24/2017)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... nervous system (CNS) diseases, is pleased to announce that ... with the U.S. Food and Drug Administration (FDA), a ... LevoCap ER (REL-1015, levorphanol extended release, abuse deterrent capsules) ... filing is achievable.   "The FDA,s input ...
Breaking Biology Technology:
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
Breaking Biology News(10 mins):